| Trial Identifier: | D5180R00024 |
| Sponsor: | AstraZeneca |
| Collaborator: |
IQVIA Ltd.
|
| Start Date: | September 2025 |
| Primary Completion Date: | May 2029 |
| Study Completion Date: | May 2029 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Denmark | Copenhagen, Denmark |
| France | Paris, France |
| Germany | Berlin, Germany |
| United States, DE | Wilmington, DE, United States, 19801 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company